FDA Inspection 992370 — Octapharma Plasma, Inc. Portsmouth

Octapharma Plasma, Inc. Portsmouth — FEI 3007166600

The FDA completed an inspection of Octapharma Plasma, Inc. Portsmouth on October 28, 2016 in Portsmouth, VA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 28, 2016
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Portsmouth, VA (United States)

Citations

IDCFRDescription
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs